DeepMind spinout Isomorphic Labs in talks to raise funds at $40B–$50B valuation
FROM THE WIRE · SEEKINGALPHA.COM
Isomorphic Labs, DeepMind’s AI drug discovery startup, may raise new funding at a $40B–$50B valuation, per Bloomberg.
Read at the source ↗MARKET IMPACTHIGH✦ News Impact agent estimateTone: expected bullishA $40-50B valuation for an AI drug discovery startup signals massive confidence in biotech-AI and moves Google and tech stocks.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Isomorphic Labs, a DeepMind spinout, is raising funds at a $40-50B valuation.
- 02The company specializes in AI-driven drug discovery.
- 03The valuation reflects growing investor interest in AI applications in pharmaceuticals.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets